- Home
- MDIA vs MGX Comparison
MDIA vs MGX Comparison
Compare MDIA & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- MGX
- Stock Information
- Founded
- MDIA 2019
- MGX 2018
- Country
- MDIA United States
- MGX United States
- Employees
- MDIA N/A
- MGX N/A
- Industry
- MDIA Broadcasting
- MGX
- Sector
- MDIA Consumer Discretionary
- MGX
- Exchange
- MDIA Nasdaq
- MGX NYSE
- Market Cap
- MDIA 51.8M
- MGX 62.1M
- IPO Year
- MDIA N/A
- MGX 2024
- Fundamental
- Price
- MDIA $1.16
- MGX $1.79
- Analyst Decision
- MDIA
- MGX Strong Buy
- Analyst Count
- MDIA 0
- MGX 4
- Target Price
- MDIA N/A
- MGX $13.00
- AVG Volume (30 Days)
- MDIA 44.1K
- MGX 297.1K
- Earning Date
- MDIA 05-20-2025
- MGX 05-13-2025
- Dividend Yield
- MDIA N/A
- MGX N/A
- EPS Growth
- MDIA N/A
- MGX N/A
- EPS
- MDIA N/A
- MGX N/A
- Revenue
- MDIA $116,895,000.00
- MGX $45,263,000.00
- Revenue This Year
- MDIA N/A
- MGX N/A
- Revenue Next Year
- MDIA N/A
- MGX $8.34
- P/E Ratio
- MDIA N/A
- MGX N/A
- Revenue Growth
- MDIA 268.03
- MGX N/A
- 52 Week Low
- MDIA $0.79
- MGX $1.23
- 52 Week High
- MDIA $5.73
- MGX $6.90
- Technical
- Relative Strength Index (RSI)
- MDIA 67.84
- MGX 57.24
- Support Level
- MDIA $0.95
- MGX $1.59
- Resistance Level
- MDIA $1.30
- MGX $1.82
- Average True Range (ATR)
- MDIA 0.09
- MGX 0.11
- MACD
- MDIA 0.04
- MGX 0.02
- Stochastic Oscillator
- MDIA 93.00
- MGX 88.61
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.